Pages that link to "Q44031791"
Jump to navigation
Jump to search
The following pages link to Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-contain (Q44031791):
Displaying 50 items.
- Health implications of fructose consumption: A review of recent data (Q21245059) (← links)
- Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells (Q24321472) (← links)
- Fructose, insulin resistance, and metabolic dyslipidemia (Q24556527) (← links)
- Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance (Q24648189) (← links)
- Mechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat Strain (Q28066227) (← links)
- The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis (Q30249128) (← links)
- More pieces of the fructose puzzle (Q33365632) (← links)
- CFTR depletion results in changes in fatty acid composition and promotes lipogenesis in intestinal Caco 2/15 cells (Q33576842) (← links)
- Role of the Enterocyte in Fructose-Induced Hypertriglyceridaemia (Q33616687) (← links)
- An In Vivo Magnetic Resonance Spectroscopy Study of the Effects of Caloric and Non-Caloric Sweeteners on Liver Lipid Metabolism in Rats (Q33749401) (← links)
- Chronic Fructose Ingestion as a Major Health Concern: Is a Sedentary Lifestyle Making It Worse? A Review (Q33851818) (← links)
- Treatment of Dyslipidemias to Prevent Cardiovascular Disease in Patients with Type 2 Diabetes (Q33887783) (← links)
- Metabolic fate of fructose ingested with and without glucose in a mixed meal. (Q33963267) (← links)
- Jejunal wall triglyceride concentration of morbidly obese persons is lower in those with type 2 diabetes mellitus (Q34287860) (← links)
- Anthropometric and biochemical characteristics of patients with nonalcoholic fatty liver diagnosed by non-invasive diagnostic methods (Q34746071) (← links)
- Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes. (Q34785828) (← links)
- Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs (Q34980692) (← links)
- Diabetic dyslipidaemia: from basic research to clinical practice. (Q35139885) (← links)
- Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia (Q35209848) (← links)
- Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity (Q35209850) (← links)
- Mobilisation of enterocyte fat stores by oral glucose in humans. (Q35595712) (← links)
- Intestinal mucosal triacylglycerol accumulation secondary to decreased lipid secretion in obese and high fat fed mice (Q35775685) (← links)
- Altered intestinal functions and increased local inflammation in insulin-resistant obese subjects: a gene-expression profile analysis (Q35777615) (← links)
- Gut triglyceride production (Q35870227) (← links)
- Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome (Q35965047) (← links)
- Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine (Q35972634) (← links)
- Deciphering the roles of the constitutive androstane receptor in energy metabolism (Q36063700) (← links)
- Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome. (Q36149080) (← links)
- Lipopolysaccharide modulates neutrophil recruitment and macrophage polarization on lymphatic vessels and impairs lymphatic function in rat mesentery (Q36422582) (← links)
- Arterial retention of remnant lipoproteins ex vivo is increased in insulin resistance because of increased arterial biglycan and production of cholesterol-rich atherogenic particles that can be improved by ezetimibe in the JCR:LA-cp rat (Q36522670) (← links)
- Intestinal epithelial stem cells and progenitors (Q36671418) (← links)
- Effect of Pitavastatin Treatment on ApoB-48 and Lp-PLA₂ in Patients with Metabolic Syndrome: Substudy of PROspective Comparative Clinical Study Evaluating the Efficacy and Safety of PITavastatin in Patients with Metabolic Syndrome (Q36716991) (← links)
- Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects (Q37014923) (← links)
- FoxO1 integrates insulin signaling to VLDL production (Q37148966) (← links)
- Chylomicron remnants are increased in the postprandial state in CD36 deficiency. (Q37151867) (← links)
- Dietary sugars: a fat difference (Q37170782) (← links)
- Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease (Q37230527) (← links)
- Prandial hypertriglyceridemia in metabolic syndrome is due to an overproduction of both chylomicron and VLDL triacylglycerol (Q37333546) (← links)
- Insulin receptor isoform switching in intestinal stem cells, progenitors, differentiated lineages and tumors: evidence that IR-B limits proliferation (Q37386140) (← links)
- Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans (Q37418446) (← links)
- Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance. (Q37590276) (← links)
- Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin (Q37639153) (← links)
- Postprandial Hyperlipidemia and Remnant Lipoproteins (Q37639159) (← links)
- FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. (Q37648011) (← links)
- The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome (Q37724585) (← links)
- Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome (Q37786147) (← links)
- New Insights Into How the Intestine Can Regulate Lipid Homeostasis and Impact Vascular Disease: Frontiers for New Pharmaceutical Therapies to Lower Cardiovascular Disease Risk (Q37860660) (← links)
- Gut-liver interaction in triglyceride-rich lipoprotein metabolism (Q37892758) (← links)
- Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia (Q38089264) (← links)
- Insights from human congenital disorders of intestinal lipid metabolism (Q38267212) (← links)